Given that MYH9-RD is a lifelong condition with potential for late-onset systemic complications such as nephropathy, hearing loss, and cataract, a multidisciplinary follow-up plan is critical, even in asymptomatic pediatric patients. This evidence concerns the gene MYH9 and Nephropathy.